Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors

Lignende værker

• ALGORITHMS FOR MANAGEMENT OF PATIENTS WITH ADVERSE EVENTS ON THERAPY WITH TYROSINE KINASE INHIBITORS EGFR
  af: D. D. SAKAEVA
  Udgivet: (2017-06-01)
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
  af: Scagliotti, Giorgio, et al.
  Udgivet: (2010)
• Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
  af: Califano, R., et al.
  Udgivet: (2015)
• Predictive Value of In Vitro Mutation Data to Guide Second-Generation Tyrosine Kinase Inhibitor Selection: Ready for Prime Time?
  af: Silver, Richard T.
  Udgivet: (2011)
• Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancer
  af: Hirsh, V.
  Udgivet: (2011)